Fig. 3From: Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case reportPET/CT scan showed typical imaging alternations in the anastomotic region (a, c) and right iliac bone region (b, d), which was suspected of disease recurrenceBack to article page